NASDAQ:BLI • US0843101017
The current stock price of BLI is 1.2 USD. In the past month the price decreased by -27.71%. In the past year, price decreased by -82.27%.
ChartMill assigns a fundamental rating of 3 / 10 to BLI. The financial health of BLI is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months BLI reported a non-GAAP Earnings per Share(EPS) of -1.43. The EPS decreased by -33.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.1 |
11 analysts have analysed BLI and the average price target is 7.65 USD. This implies a price increase of 537.5% is expected in the next year compared to the current price of 1.2.
For the next year, analysts expect an EPS growth of 24.43% and a revenue growth 11.33% for BLI
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.77 | 194.032B | ||
| DHR | DANAHER CORP | 24.63 | 149.099B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 142.41 | 47.173B | ||
| A | AGILENT TECHNOLOGIES INC | 20.55 | 35.129B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.84 | 28.325B | ||
| IQV | IQVIA HOLDINGS INC | 12.6 | 27.528B | ||
| WAT | WATERS CORP | 22.55 | 19.513B | ||
| ILMN | ILLUMINA INC | 23.74 | 18.418B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.26 | 17.569B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.31 | 12.535B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. The company is headquartered in Emeryville, California and currently employs 285 full-time employees. The company went IPO on 2020-07-17. The firm is focused on enabling and accelerating the development and commercialization of biotherapeutics and other cell-based products. The firm's Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Its platform delivers live biology in the form of cell-based products. Its platform is a fully integrated, end-to-end solution, comprised of advanced automation systems, consumables, including OptoSelect chips and reagent kits, and advanced application and workflow software. The Company’s platform OptoElectro Positioning (OEP) technology that provides deterministic positioning of living single cells and other micro-objects using light. Its platform also uses its NanoPen technology.
BERKELEY LIGHTS INC
5858 Horton Street, Suite 320
Emeryville CALIFORNIA 94608 US
CEO: Eric Hobbs
Employees: 285
Phone: 15108582855.0
Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. The company is headquartered in Emeryville, California and currently employs 285 full-time employees. The company went IPO on 2020-07-17. The firm is focused on enabling and accelerating the development and commercialization of biotherapeutics and other cell-based products. The firm's Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Its platform delivers live biology in the form of cell-based products. Its platform is a fully integrated, end-to-end solution, comprised of advanced automation systems, consumables, including OptoSelect chips and reagent kits, and advanced application and workflow software. The Company’s platform OptoElectro Positioning (OEP) technology that provides deterministic positioning of living single cells and other micro-objects using light. Its platform also uses its NanoPen technology.
The current stock price of BLI is 1.2 USD. The price decreased by -5.88% in the last trading session.
BLI does not pay a dividend.
BLI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
11 analysts have analysed BLI and the average price target is 7.65 USD. This implies a price increase of 537.5% is expected in the next year compared to the current price of 1.2.
BERKELEY LIGHTS INC (BLI) currently has 285 employees.
BERKELEY LIGHTS INC (BLI) will report earnings on 2023-05-08, after the market close.